AGER and acute respiratory distress syndrome: In this study, we demonstrated that both sRAGE and anti-RAGE antibody had similar therapeutic effects in experimental ARDS, with improved arterial oxygenation, restored AFC, and attenuated histological lung injury, alveolar capillary permeability and inflammation.